Related Experiment Video
Updated: Jul 12, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
Initial cardioplegia dose indexed to left ventricular mass in mitral valve surgery
Sitong Tang1, Xinglei Ren2, Chiyin Wang2
1Wenzhou Medical University, Wenzhou, China.
Insights
Dosing cardioplegia by left ventricular (LV) mass in mitral valve surgery revealed a nonlinear dose-response. Higher LV mass-indexed doses correlated with increased cardiac enzyme release, suggesting caution above 12.2 mL/g.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Current cardioplegia dosing in mitral valve surgery relies on body weight or surface area (BSA), potentially not reflecting actual cardiac mass.
- This study investigates if indexing the initial cardioplegia dose to left ventricular (LV) mass improves dosing accuracy.
Purpose of the Study:
- To evaluate the efficacy of left ventricular (LV) mass-indexed cardioplegia dosing compared to standard BSA-based methods.
- To identify potential thresholds for cardioplegia dosing that correlate with myocardial injury markers.
Main Methods:
- Retrospective analysis of 323 mitral surgery patients receiving St. Thomas cardioplegia solution.
- Calculation of two LV mass indices: C1 (dose/LV mass) and C2 (dose/LV mass index).
- Propensity score matching (PSM) used to compare groups with different C1 values, assessing CK-MB mass and hs-cTnT levels.
Main Results:
- A nonlinear association was observed between the C1 index and CK-MB mass, with a threshold near 12.2 mL/g.
- Higher C1 values (Group B) were associated with increased CK-MB mass post-surgery.
- Model performance favored the LV mass-indexed C1 over BSA-indexed C2 for predicting outcomes.
Conclusions:
- Left ventricular (LV) mass-indexed cardioplegia dosing demonstrates a relevant nonlinear dose-response relationship.
- Dosing values exceeding approximately 12.2 mL/g may indicate a threshold for increased myocardial injury risk.
- This approach offers improved fidelity in cardioplegia administration during mitral valve surgery.
Abstract:
BackgroundIn mitral valve surgery, cardioplegia is commonly dosed by body weight or body surface area (BSA), which may not reflect true cardiac mass. We evaluated whether indexing the initial dose to left ventricular (LV) mass improves dosing fidelity.MethodsWe retrospectively studied 323 patients undergoing mitral surgery with St. Thomas solution (2019-2022). The initial dose of cardioplegia was based on a flow of 150 mL · min-1 · m-2 of body surface area. To reduce heterogeneity related to differences in ventricular remodeling and cardioplegia delivery strategies, the study was restricted to patients undergoing mitral valve surgery. Echocardiography-derived LV mass yielded two indices: C1 = initial perfusion dose (mL)/LV mass (g) and C2 = initial perfusion dose (mL)/LV mass index (LVMI, calculated as LV mass divided by body surface area [BSA]). Patients were divided into 2 groups, Group A (C1 ≤ 6.6 mL·g-1) and Group B (C1 > 6.6 mL·g-1). Primary endpoint was CK-MB mass (a quantitative measure of the creatine kinase-MB) at 0, 7, 24, and 48 h. High-sensitivity cardiac troponin T (hs-cTnT), ICU and hospital stay were also evaluated. Restricted cubic splines and segmented regression assessed nonlinearity and thresholds; propensity score matching (PSM) generated 67 pairs. Model performance was evaluated using the Akaike and Bayesian information criteria (AIC/BIC).ResultsIn unmatched and matched analyses, C1 showed a nonlinear association with CK-MB mass, with a threshold near C1 = 12.2 mL·g-1, above which CK-MB increased more steeply. C2 displayed higher thresholds (17.5). After PSM, Group B (higher C1) had higher CK-MB mass at 0, 24, and 48 h; hs-cTnT at 24 h was slightly higher in Group A. ICU and hospital stay were similar between groups. Model fit favored C1 over C2 at 24 and 48 h (lower AIC/BIC).ConclusionsLV-mass-indexed dosing captures a nonlinear relevant dose-response and suggests that C1 values above approximately 12.2 mL·g-1 may represent a potential upper range that warrants caution.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
